» Articles » PMID: 35276673

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022

Abstract

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.

Citing Articles

Sex differences in laryngeal cancer treated with COtransoral laser microsurgery: a case-control study.

Vilaseca I, Sampieri C, Lehrer E, Ramirez R, Costa J, Valduvieco I Eur Arch Otorhinolaryngol. 2025; .

PMID: 40087170 DOI: 10.1007/s00405-025-09315-x.


Necessity of selective neck dissection for T1-2N0 TSCC patients: a retrospective cohort study.

Chen G, Kong X, Feng Z, Kang J, Han Z, Li B BMC Oral Health. 2025; 25(1):383.

PMID: 40082913 PMC: 11907896. DOI: 10.1186/s12903-025-05694-z.


Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma.

Kim C, Han M, Kim G, Son W, Kim J, Gil M Cancer Immunol Immunother. 2025; 74(4):144.

PMID: 40063100 PMC: 11893940. DOI: 10.1007/s00262-025-03959-8.


Multi-omics insights into the molecular signature and prognosis of hypopharyngeal squamous cell carcinoma.

Ren Y, Xiong W, Feng C, Yu D, Wang X, Yang Q Commun Biol. 2025; 8(1):370.

PMID: 40044946 PMC: 11882983. DOI: 10.1038/s42003-025-07700-0.


Psychometric evaluation of the Chinese version of the Patient Self-Advocacy Scale using classical test theory and item response theory.

Cui J, Wang J, Yue A, Cao J, Zhang Z, Shi B Sci Rep. 2025; 15(1):6871.

PMID: 40011690 PMC: 11865501. DOI: 10.1038/s41598-025-91129-2.